POL HCQ ethics
K |
|||
| Zeile 16: | Zeile 16: | ||
{{tp|p=32881845|t=2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.|pdf=|usr=019}} | {{tp|p=32881845|t=2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.|pdf=|usr=019}} | ||
{{tp|p=32955801|t=2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.|pdf=|usr=019}} | {{tp|p=32955801|t=2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.|pdf=|usr=019}} | ||
| + | {{tp|p=33074933|t=2020. Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.|pdf=|usr=020}} | ||
| + | {{tp|p=33077974|t=2020. Latin America's embrace of an unproven COVID treatment is hindering drug trials.|pdf=|usr=020}} | ||
Version vom 24. Dezember 2020, 14:13 Uhr
| Politics main page |
32279469 2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.
32238355 2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.
32294807 2020. Hydroxychloroquine use during the COVID-19 pandemic 2020.
32389025 2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
32450097 2020. Prescription Restrictions on Hydroxychloroquine Among the Largest Florida Pharmacy Chains During the COVID-19 Pandemic: An Observational Study.
32451256 2020. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
32467095 2020. Covid-19: WHO halts hydroxychloroquine trial to review links with increased mortality risk.
32471832 2020. Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis.
32542496 2020. Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing.
32620062 2020. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.
32662406 2020. Pseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic.
32738852 2020. Hydroxychloroquin for COVID-19 Why was so much hype?
32875045 2020. L'hydroxy-chloroquine pour traiter les patients infectes du COVID-19: quelques lecons d'an-thropologie medicale et d'histoire de la medecine.
32881845 2020. Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment - United States, January-June 2020.
32955801 2020. Hydroxychloroquine for prophylaxis of COVID-19 physicians survey: Despite lack of evidence, many would take or give to dear ones, and despite the perceived necessity of an RCT, few would participate.
33074933 2020. Management of Irrational Self-Purchase of Hydroxychloroquine During the COVID-19 Pandemic: Experiences From the Largest Healthcare System in Taiwan.
33077974 2020. Latin America's embrace of an unproven COVID treatment is hindering drug trials.
